MGLL and migraine disorder: The findings provide further evidence in favor of a possible role of the endocannabinoid system in migraine pathophysiology but do not provide conclusive data regarding the specific importance of dual FAAH/MAGL inhibition as a potential migraine treatment versus single enzymatic inhibition.